Monthly Archives: October 2018

25Oct/18

Targeted Killing of Breast Cancer Cells by p95HER2-T Cell Bispecific Antibody

October 25, 2018Bispecific Antibody Research, NewsBreast Cancer, p95HER2, T Cell Bispecific Antibodybiobsab

Immunotherapy was positioned as an emerging and even promising treatment for cancer. Today’s new immunotherapeutic agents for different tumor types, whether used alone or in combination, are increasingly becoming one of theRead More…

02Oct/18

The World’s First-and-Only Bispecific T Cell Engager Immunotherapy Approved in Japan

October 2, 2018Bispecific Antibody Research, NewsBispecific T Cell Engager, Immunotherapybiobsab

Amgen, the United States biotechnology giant, recently announced that the Ministry of Health, Labor and Welfare (MHLW) has approved bispecific T cell engager immunotherapy Blincyto® (blinatumomab) for the treatment of relapsed orRead More…

Bispecific Antibody Research
Bispecific Antibody Clinic
News